Immunomedics Says SC Veltuzumab Produced High Response Rate In Relapsed ITP NASDAQ Responses occurred across all doses tested, including the lowest dose at 80 mg, regardless of the route of administration, history of splenectomy or prior use of rituximab. The durable complete response rate was 18 percent. ITP is an autoimmune disease ... Immunomedics Reports Subcutaneous Injections of Low-Dose Veltuzumab Produced ... Immunomedics Veltuzumab showed efficacy in ITP Immunomedics Reports Subcutaneous Injections of Low-Dose Veltuzumab Produced ... |
